6SV-24532-96257

2 vaccinations 6 coded responses 10 check-ins 6 free-text entries 5 call cases

Sex: Female
Age at first dose: 41-45
ZIP prefix: 033 / NH
Registered: 2021-04-22

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-03-29
Dose 1 — Pfizer-BioNTech
2021-04-20
Dose 2 — Pfizer-BioNTech
2021-04-22
Registered in v-safe
2021-04-22
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · Headache

Adult check-in
2021-04-27
Health check-in — day 7, dose 2
Feeling: Fair · Headache, Nausea

Adult check-in
2021-05-04
Survey response — day 14, dose 2
MedDRA: Dizziness, Migraine, Office visit — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Migraine and dizziness. Dizzy since 4/20 (first shot) and migraine since 4/25. Has not improved even with medicine and two healthcare visits for additional medicine.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-04
Report sent to call center — day 14, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-11
Survey response — day 21, dose 2
MedDRA: Dizziness, Migraine — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Migraine with dizziness has not stopped.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-11
Report sent to call center — day 21, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-05-18
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-05-25
Survey response — day 35, dose 2
MedDRA: Migraine, Vertigo — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: My migraine and vertigo have returned.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-01
Survey response — day 42, dose 2
MedDRA: Migraine — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation

Free text: Migraine has retuned and cannot be broken with typical meds. Currently on day 8. I had a three week migraine following the second shot, with about a week of a break.

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-01
Report sent to call center — day 42, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-07-22
Survey response — 3 months, dose 2
MedDRA: Lyme disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization

Free text: Lyme disease diagnosis

MedDRA releases: 2024-11 · check-in free text available
2021-07-22
Report sent to call center — 3 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

1 call case(s)
2021-07-28
Call 1 — Left Voicemail
2021-10-19
Survey response — 6 months, dose 2
MedDRA: Blood immunoglobulin G increased, Blood immunoglobulin M increased, Epstein-Barr virus antibody positive, General physical health deterioration — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: EBV and CMV positive IGG and IGM antibodies, Lyme negative (positive in June). Overall health improving significantly, but not back to pre-vaccine health.

MedDRA releases: 2024-11 · check-in free text available
2021-10-19
Report sent to call center — 6 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · 1 call case(s)
2021-10-20
Call 1 — Left Voicemail
2021-10-20
Call successful
Participant prefers to complete VAERS report online
2021-10-20
Call successful
Participant prefers to complete VAERS report online
2022-04-20
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-03-29	Pfizer-BioNTech
2	2021-04-20	Pfizer-BioNTech

Call center

5 call center cases

5 successful

See the call center timeline

Free text

Release 8 — day 14, dose 2

2021-05-04

Symptoms: Migraine and dizziness. Dizzy since 4/20 (first shot) and migraine since 4/25. Has not improved even with medicine and two healthcare visits for additional medicine.

Release 8 — day 21, dose 2

2021-05-11

Symptoms: Migraine with dizziness has not stopped.

Release 8 — day 35, dose 2

2021-05-25

Symptoms: My migraine and vertigo have returned.

Release 8 — day 42, dose 2

2021-06-01

Symptoms: Migraine has retuned and cannot be broken with typical meds. Currently on day 8. I had a three week migraine following the second shot, with about a week of a break.

Release 9 — 3 months, dose 2

2021-07-22

Symptoms: Lyme disease diagnosis

Release 10 — 6 months, dose 2

2021-10-19

Symptoms: EBV and CMV positive IGG and IGM antibodies, Lyme negative (positive in June). Overall health improving significantly, but not back to pre-vaccine health.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Blood immunoglobulin G increased	·	·	✓
SD	Blood immunoglobulin M increased	·	·	✓
SD	Dizziness	✓	✓	✓
SD	Epstein-Barr virus antibody positive	·	·	✓
SD	General physical health deterioration	·	·	✓
SD	Lyme disease	·	·	✓
SD	Migraine	✓	✓	✓
SD	Office visit	✓	✓	✓
SD	Vertigo	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release